Get Premium to unlock powerful stock data

AquaBounty Technologies, Inc. Announces Results for the Quarter and Six Months Ended June 30, 2019

Author's Avatar
Aug 08, 2019
Article's Main Image

MAYNARD, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. ( AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, announces the Company’s financial results for the second quarter and six months ended June 30, 2019.

Financial and Operational Summary:

  • Stocked the Company’s Indiana and Rollo Bay farm sites with AquAdvantage Salmon eggs to commence grow-out and proceed toward commercialization;
  • completed a second public offering of common shares, raising net funds of $5.8 million;
  • with commercial facilities now employed, completed the close-down of the Company’s demonstration farm in Panama;
  • net loss for the six-month period ended June 30, 2019, increased to $6.8 million from $5.2 million in the corresponding period of the previous year, and net loss for the three-month period ended June 30, 2019, increased to $4.0 million from $2.8 million in the corresponding period of the previous year, due to increases in headcount and associated ramp-up costs at the Company’s grow-out farm in Indiana, stock compensation charges, and legal fees in support of the U.S. Food and Drug Administration’s (FDA) defense of their approval of AquAdvantage Salmon; and
  • cash at June 30, 2019, was $10.4 million (December 31, 2018: $3.0 million).

Sylvia Wulf, Chief Executive Officer of AquaBounty, stated: “This past quarter was an historic one for AquaBounty, as the FDA’s lifting of the Import Alert on AquAdvantage Salmon allowed us to stock our eggs at our Indiana farm site and, for the first time ever, grow our fish in the United States. We also stocked our new farm in Rollo Bay on Prince Edward Island and completed a second equity fundraise to continue to improve our balance sheet.

“I am also pleased to welcome David Melbourne, Jr. to AquaBounty in his new role as Chief Commercial Officer and I would like to announce the appointment of Dr. Mark Walton to the position of Vice President of Research and Regulatory Affairs following the retirement of Dr. Ronald Stotish. With these changes, we continue to build and strengthen our senior management team as we move forward to execute our commercial plan.”

About AquaBounty Technologies:

AquaBounty is a leader in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability. The Company’s objective is to ensure the availability of high-quality seafood to meet global consumer demand, while addressing critical production constraints in the most popular farmed species. For more information about AquaBounty, visit

Forward-Looking Statements:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. All statements other than statements of historical fact contained in this press release are forward-looking statements, including statements regarding the potential for grow-out of our fish at our Indiana and Rollo Bay facilities, the commercialization of our products, and the execution of our commercial plan. Forward-looking statements may be identified with words such as “will,” “may,” “expect,” “plan,” “anticipate,” “upcoming,” “believe,” “estimate,” or similar terminology, and the negative of these terms. Forward-looking statements are not promises or guarantees of future performance and are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Forward-looking statements speak only as of the date hereof, and, except as required by law, we undertake no obligation to update or revise these forward-looking statements. For additional information regarding these and other risks faced by us, please refer to our public filings with the Securities and Exchange Commission (“SEC”), available on the Investors section of our website at and on the SEC’s website at

AquaBounty Technologies, Inc.
Consolidated Balance Sheets

As of
June 30,December 31,
Current assets:
Cash and cash equivalents$10,400,795$2,990,196
Certificate of deposit12,86612,361
Other receivables109,896115,982
Prepaid expenses and other current assets555,946315,969
Total current assets11,289,8483,510,617
Property, plant and equipment, net24,621,30923,716,768
Right of use assets, net426,735
Definite-lived intangible assets, net164,440171,292
Indefinite-lived intangible assets191,800191,800
Other assets80,58380,583
Total assets$36,774,715$27,671,060
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued liabilities$1,977,030$824,900
Other current liabilities68,43220,423
Current debt139,27471,613
Total current liabilities2,184,736916,936
Long-term lease obligations384,507
Long-term debt4,487,0043,519,821
Total liabilities7,056,2474,436,757
Commitments and contingencies
Stockholders’ equity:
Common stock, $0.001 par value, 50,000,000 shares authorized;
21,598,555 (2018: 15,098,837) shares outstanding21,59815,099
Additional paid-in capital155,803,946142,707,957
Accumulated other comprehensive loss(401,846)(574,186)
Accumulated deficit(125,705,230)(118,914,567)
Total stockholders’ equity29,718,46823,234,303
Total liabilities and stockholders’ equity$36,774,715$27,671,060

AquaBounty Technologies, Inc.
Consolidated Statements of Operations and Comprehensive Loss

Three Months Ended
June 30,
Six Months Ended
June 30,
Product revenues$42,486$47,898$140,371$66,995
Costs and expenses
Product costs38,99247,287120,60563,519
Sales and marketing103,39076,381175,381158,028
Research and development813,449880,8221,476,9301,858,639
General and administrative3,106,3741,827,9915,142,8683,214,864
Total costs and expenses4,062,2052,832,4816,915,7845,295,050
Operating loss(4,019,719)(2,784,583)(6,775,413)(5,228,055)
Other income (expense)
Gain on disposal of equipment8,54810,5858,54811,745
Interest expense(14,212)(5,283)(27,550)(10,685)
Other income (expense), net(1,348)(1,868)3,752(3,941)
Total other income (expense)(7,012)3,434(15,250)(2,881)
Net loss$(4,026,731)$(2,781,149)$(6,790,663)$(5,230,936)
Other comprehensive income (loss):
Foreign currency translation income (loss)84,788(85,811)172,340(197,929)
Total other comprehensive income (loss)84,788(85,811)172,340(197,929)
Comprehensive loss$(3,941,943)$(2,866,960)$(6,618,323)$(5,428,865)
Basic and diluted net loss per share$(0.19)$(0.22)$(0.37)$(0.42)
Weighted average number of common shares -
basic and diluted21,313,05512,787,76118,515,90712,366,657

For more information, contact:
Dave Conley
Corporate Communications
AquaBounty Technologies, Inc.
+1 613 294 3078

0 / 5 (0 votes)
Author's Avatar

GuruFocus Screeners

Related Articles